BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36870011)

  • 1. Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis.
    Zhang YC; Fan KY; Wang Q; Hu JX; Wang Q; Zhang HY; Song S; Zhao R; Qiao J; Zhang SX
    Neurol Ther; 2023 Jun; 12(3):751-762. PubMed ID: 36870011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Evidence Supporting Causal Roles of mTOR-Dependent Proteins in Rheumatic Fever: A Two-Sample Randomized Mendelian Study.
    Mu YF; Wang Q; Hu JX; Wang Q; Zhang YC; Fan KY; Han ZY; Zhang HY; Cheng T; Zhao R; Song S; Qiao J; Zhang SX; Wang CH
    Adv Ther; 2023 Apr; 40(4):1590-1600. PubMed ID: 36773079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causal Association Between mTOR-Dependent Protein Levels and Alzheimer's Disease: A Mendelian Randomization Study.
    Cai HY; Hou SJ; Wen R; Feng QF; Xi YJ; Zhang SX; Qiao J; Wu MN
    J Alzheimers Dis; 2023; 94(4):1477-1485. PubMed ID: 37393500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of mTORC1‑dependent circulating protein levels with cataract formation: a mendelian randomization study.
    Cai Y; Liu K; Wu P; Yuan R; He F; Zou J
    BMC Genomics; 2022 Oct; 23(1):719. PubMed ID: 36271348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal association between mTOR-dependent EIF-4E and EIF-4A circulating protein levels and type 2 diabetes: a Mendelian randomization study.
    Soliman GA; Schooling CM
    Sci Rep; 2020 Sep; 10(1):15737. PubMed ID: 32978410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The causal effect of mTORC1-dependent circulating protein levels on nonalcoholic fatty liver disease: A Mendelian randomization study.
    Yan X; Huang S; Li H; Feng Z; Kong J; Liu J
    Dig Liver Dis; 2024 Apr; 56(4):559-564. PubMed ID: 37778897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study.
    Lu H; Wu PF; Zhang W; Xia K
    Mult Scler Relat Disord; 2020 Sep; 44():102300. PubMed ID: 32590313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Factors and Their Roles in Multiple Sclerosis Risk.
    Lu H; Wu PF; Ma DL; Zhang W; Sun M
    Front Immunol; 2021; 12():768682. PubMed ID: 34745143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Evidence Supporting a Causal Association Between mTOR-Dependent EIF-4E Circulating Protein Level and Osteoporosis.
    Cheng T; Zhang YC; Fan KY; Hu JX; Wang Q; Wang Q; Liu L; Zhang HY; Hou YP; Li XF; Zhang SX
    Adv Ther; 2023 Nov; 40(11):4987-4998. PubMed ID: 37728694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal association between mTOR-dependent circulating protein levels and central precocious puberty: a Mendelian randomization study.
    Ying Y; Yu Z; Wu L
    Front Endocrinol (Lausanne); 2024; 15():1360043. PubMed ID: 38516410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.
    Wang R
    J Transl Med; 2022 Jan; 20(1):3. PubMed ID: 34980161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically Determined Circulating Levels of Cytokines and the Risk of Rheumatoid Arthritis.
    Qian Y; He Z; Zhao SS; Liu B; Chen Y; Sun X; Ye D; Jiang X; Zheng H; Wen C; Zheng H; Mao Y
    Front Genet; 2022; 13():802464. PubMed ID: 35198006
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis.
    Ge F; Huo Z; Li C; Wang R; Wang R; Liu Y; Chen J; Lu Y; Wen Y; Jiang Y; Peng H; Wu X; Liang H; He J; Liang W
    Mult Scler Relat Disord; 2021 Jun; 51():102927. PubMed ID: 33812221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study.
    Liu B; Lyu L; Zhou W; Song J; Ye D; Mao Y; Chen GB; Sun X
    BMC Med; 2023 Feb; 21(1):39. PubMed ID: 36737740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and Multiple Sclerosis: A Mendelian Randomization Study.
    Mokry LE; Ross S; Timpson NJ; Sawcer S; Davey Smith G; Richards JB
    PLoS Med; 2016 Jun; 13(6):e1002053. PubMed ID: 27351487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1-Dependent Protein and Parkinson's Disease: A Mendelian Randomization Study.
    Tan C; Ai J; Zhu Y
    Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
    Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
    Front Immunol; 2022; 13():956005. PubMed ID: 36159838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between accelerometer-measured and multiple sclerosis: a 2-sample Mendelian randomization study.
    Lu H; Wu PF; Li RZ; Zhang W; Huang GX
    Neurol Sci; 2021 Aug; 42(8):3337-3341. PubMed ID: 33411191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
    Mokry LE; Ross S; Ahmad OS; Forgetta V; Smith GD; Goltzman D; Leong A; Greenwood CM; Thanassoulis G; Richards JB
    PLoS Med; 2015 Aug; 12(8):e1001866. PubMed ID: 26305103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.
    Lu H; Wu PF; Zhang W; Liao X
    Front Immunol; 2021; 12():647588. PubMed ID: 33936066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.